Cargando...
Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death
In September 2020, the Japanese government approved cetuximab saratolacan (previously known as RM-1929, commercial name: Akalux) for the treatment of unresectable locally advanced or recurrent head and neck cancer. Cetuximab saratolacan is a chemical conjugate of the photosensitizer IR700 with cetux...
Gardado en:
| Publicado en: | Oncoimmunology |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7595598/ https://ncbi.nlm.nih.gov/pubmed/33178498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1841393 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|